Antifungal activity of the noncytotoxic human peptide hepcidin 20 against fluconazole-resistant Candida glabrata in human vaginal fluid

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4314-4321

  Del Gaudio, Gaetano ^a   Lombardi, Lisa ^a   Maisetta, Giuseppantonio ^a   Esin, Semih ^a   Batoni, Giovanna ^a   Sanguinetti, Maurizio ^b   Senesi, Sonia ^a   Tavanti, Arianna ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; HEPCIDIN; HUMAN PEPTIDE HEPCIDIN 20; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA GLABRATA; CANDIDIASIS; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FUNGICIDAL ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VAGINA DISCHARGE; VAGINITIS; YEAST CELL;

EID: 84882442604     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00904-13     Document Type: Article

References (39)

1. Kennedy MA, Sobel JD. 2010. Vulvovaginal candidiasis caused by nonalbicans Candida species: new insights. Curr. Infect. Dis. Rep. 12:465-470.
2. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J. Clin. Microbiol. 43:2155-2162.
3. Pfaller MA. 2012. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am. J. Med. 125(Suppl. 1):S3-S13.
4. Ostrosky-Zeichner L. 2013. Candida glabrata and FKS mutations: witnessing the emergence of the true Multidrug-Resistant Candida. Clin. Infect. Dis. 56:1733-1734.
5. Hancock RE, Sahl H-G. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
6. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
7. Joly S, Maze C, McCray PB, Jr, Guthmiller JM. 2004. Human betadefensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J. Clin. Microbiol. 42:1024-1029.
8. Helmerhorst EJ, Venuleo C, Beri A, Oppenheim FG. 2005. Candida glabrata is unusual with respect to its resistance to cationic antifungal proteins. Yeast 22:705-714.
9. Helmerhorst EJ, Venuleo C, Sanglard D, Oppenheim FG. 2006. Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5. Antimicrob. Agents Chemother. 50:1100-1103.
10. Benincasa M, Scocchi M, Pacor S, Tossi A, Nobili D, Basaglia G, Busetti M, Gennaro R. 2006. Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J. Antimicrob. Chemother. 58:950-959.
11. Tavanti A, Maisetta G, Del Gaudio G, Petruzzelli R, Sanguinetti M, Batoni G, Senesi S. 2011. Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates. Peptides 32:2484-2487.
12. Kacprzyk L, Rydengård V, Mörgelin M, Davoudi M, Pasupuleti M, Malmsten M, Schmidtchen A. 2007. Antimicrobial activity of histidinerich peptides is dependent on acidic conditions. Biochim. Biophys. Acta 1768:2667-2680.
13. Maisetta G, Petruzzelli R, Brancatisano FL, Esin S, Vitali A, Campa M, Batoni G. 2010. Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH. Peptides 31:1995-2002.
14. Wei GX, Bobek LA. 2005. Human salivary mucin MUC7 12-mer-L and 12-mer-D peptides: antifungal activity in saliva, enhancement of activity with protease inhibitor cocktail or EDTA, and cytotoxicity to human cells. Antimicrob. Agents Chemother. 49:2336-2342.
15. Batoni G, Maisetta G, Esin S, Campa M. 2006. Human beta-defensin-3: a promising antimicrobial peptide. Mini Rev. Med. Chem. 6:1063-1073.
16. Wei GX, Campagna AN, Bobek LA. 2007. Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide. Ann. Clin. Microbiol. Antimicrob. 6:14.
17. Maisetta G, Di Luca M, Esin S, Florio W, Brancatisano FL, Bottai D, Campa M, Batoni G. 2008. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 29:1-6.
18. Yeung AT, Gellatly SL, Hancock RE. 2011. Multifunctional cationic host defence peptides and their clinical applications. Cell. Mol. Life Sci. 68: 2161-2176.
19. Park CH, Valore EV, Waring AJ, Ganz T. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276:7806-7810.
20. Owen DH, Katz DF. 1999. A vaginal fluid stimulant. Contraception 59:91-95.
21. Lai BE, Xie YQ, Lavine ML, Szeri AJ, Owen DH, Katz DF. 2008. Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow. J. Pharm. Sci. 97:1030-1038.
22. Valore EV, Park CH, Igreti SL, Ganz T. 2002. Antimicrobial components of vaginal fluid. Am. J. Obstet. Gynecol. 187:561-568.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
24. Tomás MS, Nader-Macías ME. 2007. Effect of a medium simulating vaginal fluid on the growth and expression of beneficial characteristics of potentially probiotic lactobacilli, p 732-739. In Méndez-Vilas A (ed), Communicating current research, educational topics and trends in applied microbiology. Formatex, Badajoz, Spain.
25. Schägger H, von Jagow G. 1987. Tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
26. Shaw JL, Smith CR, Diamandis EP. 2007. Proteomic analysis of human cervico-vaginal fluid. J. Proteome Res. 6:2859-2865.
27. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827-4833.
28. Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. 2005. Mechanism of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob. Agents Chemother. 49:668-679.
29. Maisetta G, Vitali A, Scorciapino MA, Rinaldi AC, Petruzzelli R, Brancatisano FL, Esin S, Stringaro A, Colone M, Luzi C, Bozzi A, Campa M, Batoni G. 2013. pH-dependent disruption of Escherichia coli ATCC 25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25. FEBS J. 280:2842-2854.
30. Kubo I, Lee SH, Ha TJ. 2005. Effect of EDTA alone and in combination with polygodial on the growth of Saccharomyces cerevisiae. J. Agric. Food Chem. 53:1818-1822.
31. Sassi AB, Cost MR, Cole AL, Cole AM, Patton DL, Gupta P, Rohan LC. 2011. Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product. Antimicrob. Agents Chemother. 55:2282-2289.
32. Gil ML, Casanova M, Martínez JP. 1994. Changes in the cell wall glycoprotein composition of Candida albicans associated to the inhibition of germ tube formation by EDTA. Arch. Microbiol. 161:489-494.
33. Singh PK, Tack BF, McCray PB, Jr, Welsh MJ. 2000. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L799-805.
34. Zhuravel E, Shestakova T, Efanova O, Yusefovich Y, Lytvin D, Soldatkina M, Pogrebnoy P. 2011. Human beta-defensin-2 controls cell cycle in malignant epithelial cells: in vitro study. Exp. Oncol. 33:114-120.
35. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, Agerberth B, Gudmundsson GH, Gallo RL. 2001. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Investig. Dermatol. 117:91-97.
36. Sørensen OE, Cowland JB, Theilgaard-Mönch K, Liu L, Ganz T, Borregaard N. 2003. Wound healing and expression of antimicrobial peptides/ polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol. 170:5583-5589.
37. Hirsch T, Spielmann M, Zuhaili B, Fossum M, Metzig M, Koehler T, Steinau HU, Yao F, Onderdonk AB, Steinstraesser L, Eriksson E. 2009. Human beta-defensin-3 promotes wound healing in infected diabetic wounds. J. Gene Med. 11:220-228.
38. Jordan JB, Poppe L, Haniu M, Arvedson T, Syed R, Li V, Kohno H, Kim H, Schnier PD, Harvey TS, Miranda LP, Cheetham J, Sasu BJ. 2009. Hepcidin revisited, disulfide connectivity, dynamics, and structure. J. Biol. Chem. 284:24155-24167.
39. Moncla BJ, Pryke K, Rohan LC, Graebing PW. 2011. Degradation of naturally occurring and engineered antimicrobial peptides by proteases. Adv. Biosci. Biotechnol. 2:404-408.